Aijex Pharma International Inc. of Toyama City at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

Aijex Pharma International Inc.

3-30, Minato Irifune-Cho,, 930-0805 Toyama City
Japan

Hall map

MEDICA 2018 hall map (Hall 12): stand F53

Fairground map

MEDICA 2018 fairground map: Hall 12

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.11  Other equipment for electromedicine / medical technology

Other equipment for electromedicine / medical technology

Our products

Product category: Other equipment for electromedicine / medical technology

INJEX50 Vet

Exclusively for use on four-legged pets, feathered & scaled family members.

More Less

Product category: Other equipment for electromedicine / medical technology

Vial Adapter 14

This adapter is used to draw Insulin or any given subcutaneous liquid medication from vials having crimp diameter of 14mm. The adapter is attached onto the vial by firmly pressing it, the Injex50 ampoule is screwed on top of the adapter after opening the cap and the required amount of liquid is drawn into the ampoule for injecting.
 

More Less

About us

Company details

Welcome to Aijex Pharma International Inc.

Aijex Pharma International Inc. (API) is a Japanese Corporation primarily focused on needle-free jet injection technology apart from other specialty products.
Aijex Pharma International Inc., Japan (API) was established in June 2016 in co-operation with HNS International Inc., USA. API is currently located at Toyama Prefecture, Japan with offices in the USA & Germany.

API is now focused on further research & development of the needle-free technology with the aim of bringing it to a larger section of the society.

R&D is underway and nearing successful completion at Japan to introduce pre-fil ampoules with disposable injectors suitable for pharmaceutical formulations requiring subcutaneous injections like interferon, growth hormones etc. Pharmaceutical drug manufacturers are invited to tie-up with API for bringing this innovation to the market. For details on this technology, contact us.

More Less